Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
PharmafocusNews Register for New Alert
News for May 2006
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

PCTs hiding behind NICE decision over drug, says blindness charity
RNIB determined to overcome the 'NICE blight'..(more)

 Industry experts to advise Northwick Park investigation
Hopes that inquiry results will improve safety of future tests..(more)

 Medicom expands into branding
Medibrand to offer fresh approach to brand support services..(more)

 AstraZeneca's £702 million pounce for CAT
AstraZeneca confirms commitment to UK biotech industry..(more)

 Seroxat raises suicide risk in young adults, says GSK
New study raises safety concerns..(more)

 Blair speaks out against animal extremists
British public fed up with campaign of terror..(more)

 Kendle spends $215 million to become major clinical research player
Organisation to enhance its global competitive position..(more)

 Pfizer's smoking cessation drug approved
Good news for smokers wanting to 'kick the habit'..(more)

 UK government declares 'end to Prozac nation'
New scheme to increase use of 'talking therapies'..(more)

 Merck buys antibody design specialists
Company to re-establish reputation in R&D..(more)

 Scotland clears Femara for early breast cancer
Decision underlines north-south divide..(more)

 Janssen-Cilag submits new schizophrenia drug
New drug filed for approval in Europe..(more)

 Frontline NHS staff enlisted in fight against flab
Nearly one in four Britons obese..(more)

 AstraZeneca abandons diabetes drug over safety concerns
Company's late-stage pipeline 'looking thin'..(more)

 Sanofi profits jump in first quarter
Net profits up 54% compared to last year..(more)

 AstraZeneca to co-market nanotechnology cancer drug
Major advance in cancer treatment highly probable..(more)

 'Dawn of a new era' as nurses and pharmacists take on full prescribing
Number of appointments with GPs should decrease..(more)

 Positive results halt trial of new Herceptin rival
More women benefit from dual therapy..(more)

 AstraZeneca celebrates success of FMCG marketer recruitment
Organisation seeks talent from outside pharma industry..(more)

 MPs set to probe health service finances as 'crisis' continues
7,000 job cuts announced across health service..(more)

 Herceptin set for approval in early breast cancer
Final go-ahead in Europe expected in coming weeks..(more)

 Ex-Pfizer Stafford launches patient communication consultancy
Patient's needs are being forgotten or over-looked, says Stafford..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.